InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by REICHLING STEVEN, Chief Financial Officer. Officer active across 1 companies, notably Accelerate Diagnostics, Inc. Aggregated, 3 disclosures have been recorded. The latest transaction was filed on 26 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
057,736 shares0
Common Stock
SEC:0001628280-22-011209:0·
27,392 shares
Common Stock
SEC:0001628280-21-010334·
27,392 shares
Common Stock
SEC:0001628280-21-010334:0·
3 of 3 declarations
About REICHLING STEVEN
REICHLING STEVEN serves as Chief Financial Officer at Accelerate Diagnostics, Inc. He is responsible for the financial management of the company, including budgeting, financial reporting, and funding strategy. His expertise in finance is essential for ensuring the financial health and growth of the organization.
